Search PubMed⌕ Search

Biomedical subjects

G Wagner

Publications and source records attributed to G Wagner.

At least 487 records · Page 27Linked to original sources
PubMed1983

[Urinary tract infections after gynecological surgery].

In a ten year period we selected at random 235 patients, who underwent a vaginal or abdominal hysterectomy or a radical operation (Latzko-Meigs) and evaluated their postoperative morbidity with special regard to urinary tract infections. In the period of 1971 to 1979 we observed a significant increase of urinary tract infections following vaginal hysterectomy, especially after additional colporrhaphia, as well as a significant increase of febrile postoperative phases after radical hysterectomy. Also a shift towards so called "nosocomial bacteria" (Klebsiella, Aerobacter and Pseudomonas) was observed. We therefore changed our perioperative management of Latzko-Meigs operation (closed urine catheter system, perioperative antibiotic prophylaxis). The comparison of the groups before and after this change show a significant decrease of all signs of postoperative morbidity observed.

Adult↗
PubMed1983

Vasoactive intestinal polypeptide (VIP) increases vaginal blood flow and inhibits uterine smooth muscle activity in women.

The human vagina and uterus are heavily innervated by VIP-containing nerve fibres. In the present study, we have measured vaginal blood flow, transmucosal oxygen tension and uterine smooth muscle activity during stepwise intravenous infusion of vasoactive intestinal polypeptide (VIP) (0, 100, 300, 900 pmol kg-1 h-1) in non-pregnant women. Vaginal blood flow was measured by the heat clearance technique, transmucosal oxygen tension by an O2-electrode and uterine activity by a micro-tip pressure catheter in the uterine cavity. Arterial blood pressure, pulse frequency and the concentration of VIP in peripheral venous blood were monitored. VIP induced a concentration-dependent increase in vaginal blood flow. The transmucosal oxygen tension was not significantly changed by VIP. The maximum dose of VIP decreased systolic as well as diastolic blood pressure and increased pulse frequency. VIP inhibited uterine activity. These findings suggest that VIP participates as a neurotransmitter in the control of genital physiological responses.

Adult↗
PubMed1983

Intra-acrosomal inhibition of boar acrosin by synthetic proteinase inhibitors.

Thirteen serine proteinase inhibitors of the guanidine, monoamidine and diamidine type were tested for their ability to inhibit the proteinase acrosin present in the acrosome of ejaculated and capacitated boar spermatozoa. All compounds studied proved to be potent in-vitro inhibitors of acrosin. Inhibition constants (Ki) in the range of 1.2 x 10(-7) to 6 x 10(-8) M were found for the reversible inhibitors. The intra-acrosomal inhibition of acrosin was assessed by the gelatin substrate film method: 2 guanidinobenzoates, one monoamidine and one diamidine derivative proved to inhibit acrosin completely in intact spermatozoa. Intravenous injection of 6-amidino-2-(4-amidinophenyl)-indole had no effect on fertilization, but application of 4-nitrophenyl-4-guanidinobenzoate in a vaginal suppository gave a 50% reduction of fertilization.

Acrosin↗
PubMed1983

[Synthetic serine protease inhibitors. 29. Synthesis of alpha-arylsulphonylamino-beta-(4-amidinophenyl)ethyl-chloromethylketones and their inhibitory activity against trypsin, plasmin and thrombin].

The synthesis of alpha-arylsulphonylamino-beta-(4-amidinophenyl)ethyl-chloromethylketones, the structures of which correspond largely to those of the antiproteolytically very potent N alpha-arylsulphonylated 4-amidinophenylalaninamides, was realized starting from 4-cyanophenylalanine hydrochloride. After N alpha-arylsulphonylation this compound was converted via the acid chlorides by treatment with diazomethane into alpha-arylsulphonylamino-beta-(4-cyanophenyl)ethyl-diazomethylketones from which the corresponding chloromethylketones were afforded by treatment with concentrated hydrochloric acid. The conversion of the cyano function into the amidine function via the thiocarbamoyl and the thioimidic acid esters yielded the compounds named in the title. The substances produced no irreversible inhibition of the serine proteinases trypsin, plasmin and thrombin. Their competitive inhibitory effect was almost as potent as that of N alpha-arylsulphonylated 4-amidinophenylalanine ethylesters.

Amidines↗
PubMed1983

[Synthetic serine proteinase inhibitors. 30. Synthesis of alpha-benzoylamino-4-amidinocinnamic acid and alpha-(4-amidinobenzoylamino) cinnamic acid amides, and their inhibitory effect on trypsin-like enzymes].

To test their inhibitory activity against enzymes, the authors synthetized the compounds named in the title. The synthesis started from the corresponding azlactones 1 and 9. Subsequent aminolysis led to the alpha-benzoyl-aminocinnamic acid amides 2 and 10 which contain a cyano function. The acid amides were converted, in different ways, to the desired amidine salts 4, 7, 12 and 15. The amidines obtained showed but little inhibitory activity against the serine proteinases thrombin, trypsin and plasmin.

Amides↗
PubMed1983

Inhibition of the promotion phase in two-step carcinogenesis in forestomach epithelium of mice by the aromatic retinoid etretinate.

Carcinogenesis induced by 7,12-dimethylbenz[a]anthracene (DMBA) and 12-O-tetradecanoylphorbol 13-acetate (TPA) in the forestomach epithelium of mice was delayed by ethyl all-trans-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoate (etretinate). Beside the clear inhibitory effect during the promotion phase, however, considerable side effects occurred when administering effective doses.

9,10-Dimethyl-1,2-benzanthracene↗
PubMed1983

Recent results of the German Thorotrast study--epidemiological results and dose effect relationships in Thorotrast patients.

The German Thorotrast Study includes 5159 Thorotrast patients and 5160 control patients. 887 Thorotrast patients and 660 control patients could be clinically and biophysically examined and followed-up. The mean age at injection or hospitalization in the case of the control group was 28 yr. The mean injected volume of Thorotrast was calculated to be 24.7 ml and the X-ray films of 249 Thorotrast patients showed paravascular deposits. In the meantime 432 Thorotrast patients and 122 patients of the control group have died. Among the deceased patients we have registered (Thorotrast vs control): hepatic tumors 152/0; myeloproliferative diseases 10/0; Hodgkin's diseases 2/0; non-Hodgkin's lymphomas 5/1; bronchogenic carcinomas 13/6; pleural mesothelioma 1/0; bone sarcoma 1/1(?); sarcoma at injection site 1/0; hepatic cirrhosis 90/6; bone marrow failure 8/1; other neoplastic diseases 46/19; other non-neoplastic diseases 151/88. The cumulative incidence of liver tumors depends on the dose rate to liver tissue and is not influenced by the age at injection. A dose effect relationship for the myeloproliferative diseases is not yet apparent.

Adolescent↗
PubMed1983

[Synthesis of N alpha-(4-methylbenzoyl)-4-amidinophenyl-alaninamides and -esters].

To test their inhibitory activity against serine proteinases, especially thrombin, in comparison to the very potent N alpha-tosyl-4-amidinophenylalaninamides, the authors synthetized the compounds named in the title, which contain the p-toluoyl residue in place of the tosyl residue. These compounds were prepared from 4-cyanophenyl-alanine (1) by N-acylation to 2 and formation of the active ester 3 which was aminolyzed. The amides thus obtained were converted, via the thioamides and the thioimidic acid ester salts, to the amidine hydroiodides 16-19. The methyl ester 21 was afforded from 2 by means of the Pinner reaction.

Chemical Phenomena↗
PubMed1982

Estrogen deprivation and vaginal function in postmenopausal women.

A physiological study of the effects of menopause on vaginal function involving 14 postmenopausal women aged 51 to 70 years is reported. Initial evaluations in the estrogen-deprived state were hormonal and cytological studies, vaginal pH, quantity of vaginal fluid, transvaginal electropotential difference, and vaginal blood flow. A significant fall in vaginal pH and increases in transvaginal potential difference, the quantity of vaginal fluid, and vaginal blood flow were observed after estrogen replacement therapy. The results before and after treatment are compared with norms established for women younger than 40 years.

Aged↗
PubMed1982

Vasoactive intestinal polypeptide and the female genital tract: relationship to reproductive phase and delivery.

Recently, vasoactive intestinal polypeptide (VIP) has been localized in nerve fibers in the human female genital tract. In the present investigation, the effect and concentration of VIP was studied in uterine tissue from pregnant and nonpregnant women, and the plasma concentration of VIP was measured in relationship to diurnal rhythm, intake of food, menstrual cycle, pregnancy, labor, age, and sexual arousal. In vitro VIP inhibited the contractions of the nonpregnant but not of the pregnant uterus. The median concentration of VIP in myometrium from pregnant women (less than 0.1 pmole/gm) was significantly lower than that in myometrium from nonpregnant women (1.6 pmoles/gm). The venous plasma concentrations of VIP during labor (10.5 to 13.0 pmoles/L) were significantly higher than those during pregnancy (2.0 to 5.0 pmoles/L) and the menstrual cycle of VIP increased significantly during sexual arousal, from 4.0 to 8.5 pmoles/L. The median arterial and venous concentrations in the umbilical cord (12.5 and 14.5 pmoles/L, respectively) were significantly higher than the concentration in maternal peripheral venous blood (5.2 pmoles/L). The plasma concentrations of VIP were not related to intake of food, diurnal rhythm, menstrual cycle, or age. The conclusion is that the function of VIP may be related to pregnancy, delivery, and sexual stimulation.

Adolescent↗